Arbutus Biopharma

$3.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.18 (+5.01%) Today

+$0.07 (+1.86%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell ABUS and other stocks, options, and ETFs commission-free!

About ABUS

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA. The listed name for ABUS is Arbutus Biopharma Corporation Common Stock.

CEO

William H. Collier

Employees

Headquarters

Warminster, Pennsylvania

Founded

2005

Market Cap

320.11M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.50M

High Today

$3.87

Low Today

$3.61

Open Price

$3.61

Volume

1.81M

52 Week High

$9.02

52 Week Low

$0.88

Collections

ABUS Earnings

-$0.73

-$0.49

-$0.24

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 4, Pre-Market